New York State Common Retirement Fund
JSPR icon

New York State Common Retirement Fund’s Jasper Therapeutics JSPR Stock Holding History

New York State Common Retirement Fund’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,600
Closed -$19.8K – 3267
2025
Q1 		$19.8K Hold
4,600
– – ﹤0.01% 2982
2024
Q4 		$98.3K Hold
4,600
– – ﹤0.01% 2597
2024
Q3 		$86.5K Hold
4,600
– – ﹤0.01% 2653
2024
Q2 		$104K Buy
+4,600
New +$110K ﹤0.01% 2752

Other funds holding JSPR

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

New York State Common Retirement Fund's JSPR Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Jasper Therapeutics (JSPR) in Q2 2025, closing a stake of 4,600 shares — an estimated $19.8K sold.

New York State Common Retirement Fund first reported a position in JSPR in Q2 2024 and held it in 4 quarters. The position peaked at $104K in Q2 2024. 65 funds tracked by Wall St. Rank hold JSPR as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Jasper Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 4,600 Jasper Therapeutics shares in Q2 2025, an estimated $19.8K.
  • New York State Common Retirement Fund first reported a position in Jasper Therapeutics in Q2 2024 and held it in 4 quarters.
  • New York State Common Retirement Fund's Jasper Therapeutics position peaked at $104K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.